WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004007437) UREA-SUBSTITUTED AND URETHANE-SUBSTITUTED ACYLUREAS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/007437    International Application No.:    PCT/EP2003/006934
Publication Date: 22.01.2004 International Filing Date: 30.06.2003
Chapter 2 Demand Filed:    29.01.2004    
IPC:
C07C 275/54 (2006.01), C07D 239/96 (2006.01), C07D 295/135 (2006.01)
Applicants: AVENTIS PHARMA DEUTSCHLAND GMBH [DE/DE]; Brüningstrasse 50, 65929 Frankfurt am Main (DE)
Inventors: DEFOSSA, Elisabeth; (DE).
KADEREIT, Dieter; (DE).
KLABUNDE, Thomas; (DE).
BURGER, Hans-Joerg; (US).
HERLING, Andreas; (DE).
WENDT, Karl-Ulrich; (DE).
VON ROEDERN, Erich; (DE).
SCHOENAFINGER, Karl; (DE)
Priority Data:
102 31 371.7 11.07.2002 DE
Title (DE) HARNSTOFF- UND URETHAN-SUBSTITUIERTE ACYLHARNSTOFFE, VERFAHREN ZU DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS ARZNEIMITTEL
(EN) UREA-SUBSTITUTED AND URETHANE-SUBSTITUTED ACYLUREAS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS
(FR) ACYLUREES SUBSTITUEES PAR UREE ET URETHANE, PROCEDES PERMETTANT DE LES PRODUIRE ET LEUR UTILISATION COMME MEDICAMENTS
Abstract: front page image
(DE)Die Erfindung betrifft Harnstoff- und Urethan-substituierte Acylharnstoffe sowie deren physiologisch verträgliche Salze und physiologisch funktionellen Derivate. Die Erfindung betrifft daher Verbindungen der Formel (I), worin die Reste die angegebenen Bedeutungen haben, sowie deren physiologisch verträglichen Salze und Verfahren zu deren Herstellung. Die Verbindungen eignen sich z.B. als Antidiabetika.
(EN)The invention relates to urea-substituted and urethane-substituted acylureas, to physiologically compatible salts thereof and to their physiologically functional derivatives. The invention thus relates to compounds of formula (I), wherein the radicals have the cited meanings. The invention also relates to the physiologically compatible salts of these compounds and to methods for the production thereof. The inventive compounds are suited for use, for example, as antidiabetics.
(FR)L'invention concerne des acylurées substituées par urée et uréthane, ainsi que leurs sels physiologiquement compatibles et leurs dérivés physiologiquement fonctionnels. L'invention concerne par conséquent des composés de formule (I) dans laquelle les restes ont les significations mentionnées, ainsi que leurs sels physiologiquement compatibles et des procédés permettant de les produire. Ces composés s'utilisent par ex. comme antidiabétiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)